Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repeat FDG-PET After Neoadjuvant Therapy is a Predictor of Pathologic Response in Patients With Non-Small Cell Lung Cancer

Published:2004-12 Issue:6 Volume:78 Page:1903-1909
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Cerfolio Robert J.,Bryant Ayesha S.,Winokur Thomas S.,Ohja Buddhiwardhan,Bartolucci Alfred A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference26 articles.

1. Annual report to the nation on the status of cancer, 1975–2000, featuring the uses of surveillance data for cancer prevention;Weir;J Nat Cancer Ins,2003

2. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

3. Estimates of the worldwide incidence of eighteen major cancers in 1985;Parkin;Int J Cancer,1993

4. Multidisciplinary management of lung cancer;Spira;N Engl J Med,2004

5. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage 1 (except T1N0), II and IIIa non-small cell lung cancer;Depierre;J Clin Oncol,2002

Cited by 168 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative Predictive Factors for Tumor Regression and Survival in Non-Small Cell Lung Cancer Patients Undergoing Neoadjuvant Treatment and Lung Resection;Cancers;2024-08-20

2. Machine Learning-Based Prediction of Pathological Responses and Prognosis After Neoadjuvant Chemotherapy for Non–Small-Cell Lung Cancer: A Retrospective Study;Clinical Lung Cancer;2024-07

3. Immune checkpoint inhibition in early-stage non-small cell lung cancer;Lung Cancer;2024-07

4. Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer;Lung Cancer;2023-09

5. Evolving Therapeutic Scenario of Stage III Non-Small-Cell Lung Cancer;Clinical Medicine Insights: Oncology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3